Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...
According to the company, the suffix “-mod” in urcosimod denotes its classification as a modulator of key inflammatory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback